Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease-Reference-Cited by-同舟云学术

Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease

Published:2024-02 Issue:6 Volume:83 Page:652-664
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

McClintick Daniel J.,O’Donoghue Michelle L.,De Ferrari Gaetano M.^ORCID,Ferreira Jorge,Ran Xinhui,Im KyungAh,López J. Antonio G.,Elliott-Davey Mary,Wang Bei,Monsalvo Maria Laura,Atar Dan,Keech Anthony,Giugliano Robert P.,Sabatine Marc S.^ORCID

Funder

Amgen Inc

Publisher

Elsevier BV

Reference21 articles.

1. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N Engl J Med,2017

2. Alirocumab and cardiovascular outcomes after acute coronary syndrome;Schwartz;N Engl J Med,2018

3. Long-term evolocumab in patients with established atherosclerotic cardiovascular disease;O’Donoghue;Circulation,2022

4. Clinical benefit of evolocumab by severity and extent of coronary artery disease: analysis from FOURIER;Sabatine;Circulation,2018

5. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS);Biomedicines;2024-04-29

2. Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations;Current Opinion in Lipidology;2024-03-27

3. LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease;Journal of the American College of Cardiology;2024-02